Covered recipient · General Payments record
JORGE LUIS CABRERA
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$4,433.71
- Reported across 219 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $304.11 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $66.56 | 3 |
| ABBVIE INC. | $36.18 | 2 |
| IMPULSE DYNAMICS (USA) INC. | $35.27 | 1 |
| Radius Health, Inc. | $32.53 | 1 |
| PFIZER INC. | $29.71 | 2 |
| FIDIA PHARMA USA INC. | $21.09 | 1 |
| GlaxoSmithKline, LLC. | $20.69 | 1 |
| Abbott Laboratories | $18.54 | 1 |
| TOLMAR, INC. | $15.14 | 1 |
| Amgen Inc. | $14.53 | 1 |
| Novo Nordisk AS | $13.87 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $18.54 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124883164 | CMS |
| ABBVIE INC. | $17.98 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103402177 | CMS |
| ABBVIE INC. | $18.20 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103402179 | CMS |
| Amgen Inc. | $14.53 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117215376 | CMS |
| Fidia Pharma USA Inc. | $21.09 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141156873 | CMS |
| GlaxoSmithKline, LLC. | $20.69 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116466256 | CMS |
| Impulse Dynamics (USA) Inc. | $35.27 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100410810 | CMS |
| Lilly USA, LLC | $21.18 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135079556 | CMS |
| Lilly USA, LLC | $24.45 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135100470 | CMS |
| Lilly USA, LLC | $20.93 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135099572 | CMS |
| Novo Nordisk Inc | $13.87 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096615740 | CMS |
| PFIZER INC. | $14.03 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131116752 | CMS |
| PFIZER INC. | $15.68 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131840034 | CMS |
| Radius Health, Inc. | $32.53 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089962963 | CMS |
| Tolmar, Inc. | $15.14 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138718574 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.